Compare PTRN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTRN | STVN |
|---|---|---|
| Founded | 2013 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.9B |
| IPO Year | 2025 | 2021 |
| Metric | PTRN | STVN |
|---|---|---|
| Price | $19.66 | $20.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $19.56 | ★ $25.67 |
| AVG Volume (30 Days) | ★ 1.4M | 393.2K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $2,501,315,000.00 | N/A |
| Revenue This Year | $27.89 | $9.67 |
| Revenue Next Year | $22.19 | $9.99 |
| P/E Ratio | $65.16 | ★ $27.15 |
| Revenue Growth | ★ 39.26 | N/A |
| 52 Week Low | $9.19 | $12.89 |
| 52 Week High | $29.80 | $28.00 |
| Indicator | PTRN | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 37.22 | 44.42 |
| Support Level | $19.60 | $20.17 |
| Resistance Level | $22.79 | $20.63 |
| Average True Range (ATR) | 0.93 | 0.76 |
| MACD | -0.02 | -0.28 |
| Stochastic Oscillator | 12.73 | 20.64 |
Pattern Group Inc is an e-commerce accelerator that uses its technology platform, data science, and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics, and customer service. Brand partners that contract with the Company operate in various industries, including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors, and consumer electronics. The Company mainly derives its revenue in the United States by selling products to customers via online marketplaces. The company genrates majority of revenue from the US.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.